Editas Medicine, Inc. — Director's Dealing 2016

Sep 13, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Editas Medicine, Inc. (EDIT)
CIK: 0001650664
Period of Report: 2016-09-09

Reporting Person: Albright Charles (Chief Scientific Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-09-09	Stock Option (right to buy)	$16.51	A	225000	Acquired	2026-09-08	Common Stock (225000)	Direct

Footnotes

F1: This option was granted on September 9, 2016 and is scheduled to vest over four years with 25% of the shares scheduled to vest on August 22, 2017, and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through August 22, 2020.